Chinese consumer brands — no longer mere followers but global trendsetters — edged out stiff international competition to win ...
We must reduce the burden on traditional CI systems by bringing more testing and validation closer to the developer, be it human or agent-based.
AI and multimodal data are driving a shift toward N-of-1 medicine, tailoring interventions to a person's unique biological ...
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...
Objective Drug-related problems (DRPs), which encompass medication errors (MEs), adverse drug reactions and adverse drug events (ADEs), represent significant challenges in healthcare settings. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results